HEPATO-GASTROENTEROLOGY, cilt.57, sa.102-03, ss.1268-1271, 2010 (SCI-Expanded)
Background/Aims: HBsAg negative recipients of liver from anti-HBc positive donors are at a significant risk for developing de novo HBV infection after liver transplantation. The aim of this study was to assess the efficacy of lamivudine as mono therapy in preventing HBV transmission by graft with anti-HBc positive donors.